The biobanking industry is rapidly gaining traction across Europe, serving as a cornerstone in biomedical research, personalized medicine, and clinical studies. According to Expert Market Research, the global biobanking market was valued at USD 72.10 billion in 2024, with Europe accounting for a significant market share. As funding in healthcare RD accelerates and demand for high-quality biological samples rises, the market is projected to grow at a CAGR of 6.89% during 2025–2034, reaching approximately USD 140.38 billion by 2034.
Europe Biobanking Market Share
Europe holds a dominant position in the global biobanking sector due to its well-established healthcare infrastructure, research initiatives, and government-backed repositories. Countries like Germany, the United Kingdom, and France lead the regional market, contributing substantially to both public and private biobank operations.
Academic institutions and pharmaceutical companies are among the top end users. Moreover, the equipment and service segments contribute significantly to market share due to growing investments in sample storage, transport logistics, and cryopreservation technologies.
Europe Biobanking Market Growth Trends
Key Growth Drivers:
Increased funding for genomic and precision medicine research
Surge in clinical trials and personalized drug development
Growing awareness of bio-specimen value for cancer and chronic disease studies
Rise in regenerative medicine applications, including stem cell banking
Emerging Trends:
Integration of AI and big data analytics in biobank sample management
Advancements in automated biobanking systems for sample tracking and retrieval
Cross-border collaboration for data sharing and standardization
Expansion of population-based biobanks across Europe to facilitate epidemiological research
As explained on Wikipedia, a biobank is a type of biorepository that stores biological samples (usually human) for use in research. These samples and associated data serve as critical assets in understanding disease mechanisms, genetic variation, and therapeutic responses.
Europe Biobanking Market Case Studies News
QIAGEN N.V. announced a strategic expansion of its digital biobanking services in Germany, enabling large-scale genomic data analysis.
Merck KGaA partnered with academic consortia to advance cold-chain sample logistics.
SPT Labtech introduced next-gen biobank automation platforms to support personalized medicine in oncology.
France’s National Biobank Network received government grants to digitize and integrate more than 100 regional biorepositories.
These examples highlight the growing alignment between technological innovation and clinical research in Europe's biobanking ecosystem.
Europe Biobanking Market Analysis
Competitive Landscape:
The European biobanking market is moderately consolidated, with both global and local players competing on the basis of sample quality, innovation, and service efficiency. Key players include QIAGEN N.V., Merck KGaA, Tecan Trading AG, Micronic, and ASKION GmbH.
Market Dynamics:
Rise in chronic and rare diseases driving long-term biospecimen preservation
Ethical and regulatory standards such as GDPR impacting data handling and patient consent
Focus on cloud-based biobank software for better data interoperability
Regulatory Environment:
The European market benefits from well-defined guidelines and data governance, particularly under ISO 20387 and GDPR, ensuring quality assurance and privacy in biobanking operations.
Europe Biobanking Market Segmentation
By Product and Service:
Equipment
Consumables
Service
Software
By Application:
Regenerative Medicine
Life Science Research
Clinical Research
By Sample Type:
Blood Tissue
Nucleic Acids
Cell Lines
By End User:
Academic Institutions
Pharma and Biotech Companies
By Region:
United Kingdom
Germany
France
Italy
These segments reflect a diverse and rapidly evolving landscape, with each segment contributing uniquely to biobank growth and utilization in Europe.
Key Players in the Europe Biobanking Market
QIAGEN N.V.
Merck KGaA
Tecan Trading AG
Greiner Holding AG
Micronic
BioKryo
SPT Labtech
ASKION GmbH
CellCo BioServices
CTIBiotech
These companies are focused on improving automation, scalability, and data integrity in biobanking, forming the backbone of Europe’s robust biospecimen infrastructure.
Find More Reports
Osteoarthritis Therapeutics Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
